达比加群酯杂质 全套对照品
深圳艾利蒙生物科技有限公司可提供达比加群酯杂质全套,并随货提供COA证书,HPLC,NMR,MS图谱,10mg/25mg/50mg/100mg等多种规格可选。
部分杂质长期备有现货,可快速发货,并可根据客户需要提供杂质定制服务。
达比加群酯的相关介绍:
中文名称:达比加群酯
英文名称:dabigatran etexilate
英文别名:phenol red sodium salt;Dabigatran etexilate;phenolsulfonephthalein sodium;PHENOL RED,ACS;PR sodium salt;phenolsulfonphthalein sodium salt;phenolsulphophthaleine sodium salt;
CAS号:211915-06-9
分子式:C34H41N7O5
结构式:
分子量:627.73300
作用机理:
达比加群酯是一种新型的合成的直接凝血酶抑制剂,是dabigatran的前体药物,属非肽类的凝血酶抑制剂。口服经胃肠吸收后,在体内转化为具有直接抗凝血活性的dabigatran。dabigatran结合于凝血酶的纤维蛋白特异结合位点,阻止纤维蛋白原裂解为纤维蛋白,从而阻断了凝血瀑布网络的步骤及血栓形成。dabigatran可以从纤维蛋白一凝血酶结合体上解离,发挥可逆的抗凝作用。
达比加群酯杂质 全套对照品
达比加群酯杂质为我司优势杂质,长期备有库存,发货快。杂质结构式及更多其他杂质对照品,可进入我公司展台详细查看。
附:达比加群酯杂质列表:
中文名称 | 英文名称 |
达比加群酯标准品 | Dabigatran |
达比加群酯杂质1 | ethyl 3-(2-(iminomethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
达比加群酯杂质2 | 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid |
达比加群酯杂质3 | ethyl 3-(1-methyl-3-oxo-N-(pyridin-2-yl)-1,2,3,4-tetrahydroquinoxaline-6-carboxamido)propanoate |
达比加群酯杂质4 | methyl 3-(2-(hydroxymethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
达比加群酯杂质5 | 3-(2-(chloromethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid |
达比加群酯杂质6 | diethyl 3,3'-((2,2'-(oxybis(methylene))bis(1-methyl-1H-benzo[d]imidazole-5,5'-carbonyl))bis(pyridin-2-ylazanediyl))dipropanoate |
达比加群酯杂质7 | hexyl (imino(4-(((1-methyl-5-(pyridin-2-ylcarbamoyl)-1H-benzo[d]imidazol-2-yl)methyl)amino)phenyl)methyl)carbamate |
达比加群酯杂质8 | (Z)-3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid |
达比加群酯杂质9 | ethyl 3-(2-(((4-(((hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
达比加群酯杂质10 | (Z)-ethyl 3-(2-(((4-(N'-((hexan-2-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
达比加群酯杂质11 | (Z)-ethyl 3-(2-(((4-(N'-((hexan-3-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
达比加群酯杂质12 | ethyl 3-(1,2-dimethyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
达比加群酯杂质13 | ethyl 3-(1-methyl-2-oxo-N-(pyridin-2-yl)-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamido)propanoate |
达比加群酯杂质14 | (Z)-ethyl 2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate |
达比加群酯杂质15 | ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
达比加群酯杂质16 | ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride |
达比加群酯杂质17 | (Z)-methyl 3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
达比加群酯杂质18 | (Z)-hexyl (amino(4-(((5-((3-amino-3-oxopropyl)(pyridin-2-yl)carbamoyl)-1-methyl-1H-benzo[d]imidazol-2-yl)methyl)amino)phenyl)methylene)carbamate |
达比加群酯杂质19 | ethyl 3-(2-(((4-carbamoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
达比加群酯杂质20 | ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride |
达比加群酯杂质21 | ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate |
达比加群酯杂质22 | ethyl 3-(3-(2-((4-cyanophenyl)amino)acetamido)-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate |
深圳艾利蒙生物科技有限公司主营医药标准品及杂质对照品,所有杂质均提供HPLC,NMR,MS图谱及CoA证: 依鲁替尼杂质,骨化三醇杂质,舒更葡糖钠杂质,艾地骨化醇杂质,阿法骨化醇杂质,奥贝胆酸杂质,利伐沙班杂质,卡格列净杂质,利格列汀杂质,西格列汀杂质,埃索美拉唑杂质,LCZ696杂质,恩杂鲁胺杂质,艾曲波帕杂质,非布司他杂质,托匹司他杂质,阿维巴坦杂质,普卡必利杂质,西他沙星杂质,泊沙康唑杂质,替格瑞洛杂质,托法替尼杂质,阿奇霉素杂质等。